Bouayad-Gervais Samir, St-Cyr Daniel J, Courcelles Mathieu, Bonneil Éric, Gohard Florence H, Thibault Pierre, Earnshaw William C, Tyers Mike
Department of Medicine, Institute for Research in Immunology and Cancer Université de Montréal Montréal Canada.
Present address: X-Chem Inc., 7171 Frederick-Banting Montréal, Québec H4S 1Z9 Canada.
Pept Sci (Hoboken). 2022 May;114(3):e24254. doi: 10.1002/pep2.24254. Epub 2022 Jan 6.
Genetically-encoded cyclic peptide libraries allow rapid screens for inhibitors of any target protein of interest. In particular, the Split Intein Circular Ligation of Protein and Peptides (SICLOPPS) system exploits spontaneous protein splicing of inteins to produce intracellular cyclic peptides. A previous SICLOPPS screen against Aurora B kinase, which plays a critical role during chromosome segregation, identified several candidate inhibitors that we sought to recapitulate by chemical synthesis. We describe the syntheses of cyclic peptide hits and analogs via solution-phase macrocyclization of side chain-protected linear peptides obtained from standard solid-phase peptide synthesis. Cyclic peptide targets, including cyclo-[CTWAR], were designed to match both the variable portions and conserved cysteine residue of their genetically-encoded counterparts. Synthetic products were characterized by tandem high-resolution mass spectrometry to analyze a combination of exact mass, isotopic pattern, and collisional dissociation-induced fragmentation pattern. The latter analyses facilitated the distinction between targets and oligomeric side products, and served to confirm peptidic sequences in a manner that can be readily extended to analyses of complex biological samples. This alternative chemical synthesis approach for cyclic peptides allows cost-effective validation and facile chemical elaboration of hit candidates from SICLOPPS screens.
基因编码的环肽文库能够快速筛选任何感兴趣的靶蛋白的抑制剂。特别是,蛋白质与肽的分裂内含肽环化连接(SICLOPPS)系统利用内含肽的自发蛋白质剪接来产生细胞内环肽。之前针对在染色体分离过程中起关键作用的极光激酶B进行的SICLOPPS筛选,鉴定出了几种候选抑制剂,我们试图通过化学合成来重现这些抑制剂。我们描述了通过对从标准固相肽合成获得的侧链保护线性肽进行溶液相大环化来合成环肽命中产物及其类似物的方法。环肽靶标,包括环-[CTWAR],被设计成与其基因编码对应物的可变部分和保守半胱氨酸残基相匹配。通过串联高分辨率质谱对合成产物进行表征,以分析精确质量、同位素模式和碰撞解离诱导的碎片模式的组合。后者的分析有助于区分靶标和寡聚副产物,并以一种能够很容易扩展到复杂生物样品分析的方式来确认肽序列。这种用于环肽的替代化学合成方法能够对来自SICLOPPS筛选的命中候选物进行经济有效的验证和简便的化学修饰。